Error: Could not add to watchlist. X

Bellevue Funds Lux - BB Adamant Biotech

+ Watchlist
BBBIOCI:LX
458.59
CHF
17.55
3.69%
As of 08:56:00 ET on 06/29/2015.
Volume
0
Previous Close
476.14
52Wk Range
290.10 - 515.46
1 Yr Return
47.79%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 06/29/2015)
458.59
Total Assets (m CHF) (on 06/29/2015)
102.335
Inception Date
04/02/2009
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
CHRISTIAN LACH
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.90%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 20.00 k 7.94 m 8.09
Gilead Sciences Inc 68.00 k 7.63 m 7.78
Celgene Corp 63.00 k 7.21 m 7.35
Amgen Inc 30.87 k 4.82 m 4.92
Regeneron Pharmaceuticals Inc 9.40 k 4.82 m 4.91
Mylan NV 55.00 k 3.99 m 4.07
Vertex Pharmaceuticals Inc 28.50 k 3.66 m 3.73
Alexion Pharmaceuticals Inc 20.75 k 3.40 m 3.47
Medivation Inc 24.30 k 3.21 m 3.27
Illumina Inc 15.56 k 3.21 m 3.27
Profile
Bellevue Funds (Lux) - BB Adamant Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector.
ADDRESS
Bellevue Group AG
Seestrasse 16
Postfach
8700 Kuesnacht
Zurich
PHONE
41-44-267-67-00